Abstract: A polymerizable compound represented by formula (1): wherein each R1 independently represents at least one organic residue selected from the group consisting of alkylene groups, branched alkylene groups, cycloalkylene groups and arylene groups, R2 represents an organic residue derived from an alcohol compound, a phenol compound or a carboxylic acid compound, n represents an integer of 0 to 20, a production process of the polymerizable composition, a composition using the polymerizable compound, a cured product obtained by curing the composition and a production process of the cured product. The polymerizable compound exhibits a good adhesive property to a substrate such as glass and is imparted with radical polymerizability to enable heat curing and/or active energy ray curing.

Abstract: This invention is to provide a polymerizable composition having excellent curability and surface hardness, and a cured product thereof. A novel fumarate derivative having two or more fumarate groups within one molecule and ensuring copolymerizability with the terminal alkenyloxy group, a method for producing the derivative, a polymerizable composition containing the derivative, and a cured product thereof are provided.

Abstract: An optical pickup device according to the present invention is constituted so that a laser beam emitted from a light receiving and emitting integral-type element is transmitted or reflected by a beam splitter, transformed to a parallel beam by a collimator lens, introduced into an objective lens, transmitted through the objective lens, and collected on a recording surface of an optical disc and the laser beam thus collected is returned to the light receiving and emitting integral-type element via a reverse path after the laser beam is reflected by the recording surface of the optical disc. The optical pickup device includes a front monitor light receiving element that is arranged between the light receiving and emitting integral-type element and the collimator lens, receives a part of the laser beam emitted from the light receiving and emitting element, and detects a quantity of the received laser beam.

Abstract: An immunosuppressive agent comprising, as an effective ingredient, at least one compound selected from the group consisting of compounds represented by general formula (1) below and pharmaceutically acceptable salts thereof: wherein R101 represents an acyl residue of a higher fatty acid, and R102 represents a hydrogen atom or acyl residue of a higher fatty acid.

Abstract: A polymerizable compound represented by formula (1): wherein each R1 independently represents at least one organic residue selected from the group consisting of alkylene groups, branched alkylene groups, cycloalkylene groups and arylene groups, R2 represents an organic residue derived from an alcohol compound, a phenol compound or a carboxylic acid compound, n represents an integer of 0 to 20, a production process of the polymerizable composition, a composition using the polymerizable compound, a cured product obtained by curing the composition and a production process of the cured product. The polymerizable compound exhibits a good adhesive property to a substrate such as glass and is imparted with radical polymerizability to enable heat curing and/or active energy ray curing.

Abstract: A medicament containing at least one compound selected from the group consisting of compounds represented by General formula (1): wherein R101 represents an acyl residue of an unsaturated higher fatty acid, and R102 represents a hydrogen atom or an acyl residue of an unsaturated higher fatty acid, and pharmaceutically acceptable salts thereof, as an active ingredient.

Abstract: An immunosuppressive agent comprising, as an effective ingredient, at least one compound selected from the group consisting of compounds represented by general formula (1) below and pharmaceutically acceptable salts thereof: 1

Abstract: Novel sulforhamnosylacylglycerol derivatives represented by General Formula (1): where R101 represents an acyl residue of a higher fatty acid and R102 represents a hydrogen atom or an acyl residue of a higher fatty acid. The derivatives represented by General formula (1) are useful as, a DNA polymerase inhibitor and an anticancer agent.

Abstract: Sulfofucosylacylglycerol derivatives represented by General Formula (1): where R101 represents an acyl residue of a higher fatty acid and R102 represents a hydrogen atom or an acyl residue of a higher fatty acid. The derivatives represented by General formula (1) are useful as a DNA polymerase inhibitor and an anticancer agent.

Abstract: A method for treating a cancer. The cancer excluding an adenocarcinoma and being epithelioma, glioma, sarcoma, melanoma, lymphoma or leukemia; or the cancer is an adenocarcinoma cancer excluding colon cancer, lung cancer and gastric cancer.

Abstract: An anticancer drug includes a compound represented by Formula (1): where R101 represents an acyl moiety of a saturated higher fatty acid, and R102 represents a hydrogen atom or an acyl moiety of a saturated higher fatty acid, and/or a pharmaceutically acceptable salt thereof.

Abstract: This invention is to provide a polymerizable composition having excellent curability and surface hardness, and a cured product thereof.

Abstract: An anticancer drug includes a compound represented by Formula (1): where R101 represents an acyl moiety of a saturated higher fatty acid, and R102 represents a hydrogen atom or an acyl moiety of a saturated higher fatty acid, and/or a pharmaceutically acceptable salt thereof.

Abstract: A method for immunosuppression in a subject comprising administering to the subject in need thereof, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol derivative represented by General formula (1-1): wherein R101 represents an acyl residue of a higher fatty acid, and R102 represents a hydrogen atom or an acyl residue of a higher fatty acid; and a pharmaceutically acceptable salt thereof. Of the sulfoquinovosylacylglycerol derivatives, &bgr;-sulfoquinovosylacylglycerols are novel compounds. The present invention also relates to pharmaceutical composition comprising a pharmaceutically effective amount of the &bgr;-sulfoquinovosylacylglycerols and/or its pharmaceutically acceptable salt; and a pharmaceutically acceptable excipient. The pharmaceutical composition may be used as an immunosuppressive agent, anticancer agent and DNA polymerase &agr; inhibitor.

Abstract: An anticancer drug includes a compound represented by Formula (1): 1

Abstract: 1-O-(2-propenyl)-6-O-sulfonylpyranoside represented by the formula wherein R1, R2 and R3 each independently represents an alkyl or substituted silyl group, and R4 represents an alkylsulfonyl or arylsulfonyl group.

Abstract: 1-O-(2-propenyl)-6-deoxy-6-carbonylthiopyranoside represented by the formula wherein R1, R2 and R3 each independently represents an alkyl or a substituted silyl group, and R5 represents a hydrogen atom, or an alkyl or aryl group.

Abstract: A method for immunosuppression in a subject comprising administering to the subject in need thereof, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol derivative represented by General formula (1-1): 1

Abstract: Disclosed herein is a novel 1-alkenyl ether compound which can be cured by radical polymerization.

Abstract: A medicament containing at least one compound selected from the group consisting of compounds represented by General formula (1): 1